Healthcare and Medical

home | healthcare and medical | company profile

£265.00
Report Delivery: Via Email
Alerts
Change Currency EuroUSDGBP

Warner Chilcott Ltd - Premium Company Profile (Datamonitor)

  • Market: Healthcare and Medical
  • Published Date: 01/01/2008
  • Report Title: Warner Chilcott Ltd - Premium Company Profile
  • Table of Contents: View Table of Contents
  • Report Type: Company Profile
  • Country: Global
  • Number of Pages: 55
Introduction

Warner Chilcott is a specialty pharmaceutical company focused on two therapeutic segments: women's health and dermatology. The company's predecessor company was purchased by a private equity consortium in January 2005. The company has a strong portfolio of marketed and pipeline products.

Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies


  • Highlights

    Warner Chilcott is engaged in developing, manufacturing ,marketing and selling branded prescription products in women's healthcare and dermatology. Women's healthcare related products include Loestrin 24 FE, Ovcon 35 and Ovcon 50, Femcon FE, Estrostep FE, Femhrt and Estrace Cream and Dermatology related products include Taclonex, Dovonex and Doryx.

    The company's total revenues increased at a CAGR of 34% during 2002-2006, from $235 million to $754 million. The company's biggest contributor to revenue growth during 2002-2006 was product sales which recorded revenues of $752 million for the fiscal year 2006. The major contributors were Dovonex, Estrostep FE, Taclonex,Femhrt, and Loestrin 24 FE.

    The company's biggest contributor to sales growth out to 2010 will be the sales of Loestrin 24 FE, indicated for the prevention of pregnancy in women. Revenues from Loestrin are expected to increase at a CAGR of 59%, from $44 million in 2006 to $284 million in 2010. This represents an absolute growth of +$240 million

    Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization
  • £265.00   Share Report
     
    Alerts  

    Purchase Information

    There are various ways to purchase products from our site. Select the report title(s) you are interested in, and add it to your basket. At the Checkout page, you will be requested to submit your details. You will then have the option to pay via various methods: Debit Card ; Credit Card ; Purchase via Invoice (inc. Purchase Order no. if required) and Paypal. Companiesandmarkets.com accepts Visa, MasterCard, Diners, American Express, JCB and all the major credit cards. Companiesandmarkets.com uses RBSWorldpay.

    Once you have purchased your report(s), you will receive a confirmation email. You will then either be able to download your report(s) immediately from your Customer Area in PDF format, or the report(s) will be emailed to you directly, depending on the agreement we have with the publisher. Orders that are deliverable via email which are taken outside of working hours will be delivered next business day.

    Please note, if you purchase by invoice, you will receive your report(s) once payment has been received. If you have any questions about how to order, please Contact Us.

    Worldpay Logo
    Chancy Currency EUR USD GBP
    Customer Area
    English Italian Spanish French German Russian Chinese Arabic